TD Waterhouse Canada’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223K | Buy |
1,445
+62
| +4% | +$9.57K | ﹤0.01% | 802 |
|
|
2025
Q1 | $202K | Buy |
1,383
+32
| +2% | +$4.67K | ﹤0.01% | 794 |
|
|
2024
Q4 | $249K | Sell |
1,351
-371
| -22% | -$68.4K | ﹤0.01% | 759 |
|
|
2024
Q3 | $332K | Buy |
1,722
+301
| +21% | +$58K | ﹤0.01% | 682 |
|
|
2024
Q2 | $289K | Sell |
1,421
-71
| -5% | -$14.4K | ﹤0.01% | 696 |
|
|
2024
Q1 | $392K | Buy |
1,492
+173
| +13% | +$45.5K | ﹤0.01% | 659 |
|
|
2023
Q4 | $296K | Sell |
1,319
-7
| -0.5% | -$1.57K | ﹤0.01% | 621 |
|
|
2023
Q3 | $258K | Sell |
1,326
-24
| -2% | -$4.66K | ﹤0.01% | 606 |
|
|
2023
Q2 | $283K | Sell |
1,350
-66
| -5% | -$13.8K | ﹤0.01% | 616 |
|
|
2023
Q1 | $285K | Sell |
1,416
-25
| -2% | -$5.03K | ﹤0.01% | 605 |
|
|
2022
Q4 | $316K | Hold |
1,441
| – | – | ﹤0.01% | 592 |
|
|
2022
Q3 | $295K | Buy |
1,441
+67
| +5% | +$13.7K | ﹤0.01% | 601 |
|
|
2022
Q2 | $302K | Buy |
1,374
+5
| +0.4% | +$1.1K | ﹤0.01% | 624 |
|
|
2022
Q1 | $398K | Sell |
1,369
-146
| -10% | -$42.5K | ﹤0.01% | 627 |
|
|
2021
Q4 | $531K | Buy |
+1,515
| New | +$531K | 0.01% | 601 |
|